l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial.
about
Recent advancements in erythrocytes, platelets, and albumin as delivery systemsDrug-loaded erythrocytes: on the road toward marketing approvalDelivery of drugs bound to erythrocytes: new avenues for an old intravascular carrierNovel agents and biomarkers for acute lymphoid leukemiaTreating adults with acute lymphocytic leukemia: new pharmacotherapy options.Erythrocyte-derived photo-theranostic agents: hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications.Non-infectious chemotherapy-associated acute toxicities during childhood acute lymphoblastic leukemia therapy.Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase.International seminar on the red blood cells as vehicles for drugs.Advanced drug delivery systems for antithrombotic agents.Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase.A disseminated infection with the antifungal-multiresistant teleomorphic fungus Neocosmospora vasinfecta in a patient with acute B-lymphoblastic leukemia.Acute lymphoblastic leukemia relapsing after first-line pediatric-inspired therapy: a retrospective GRAALL study.Targeting methionine auxotrophy in cancer: discovery & exploration.Cell-based drug-delivery platforms.Engineering antiphagocytic biomimetic drug carriers.Approaches to erythrocyte-mediated drug delivery.Clofarabine for the treatment of adult acute lymphoid leukemia: the Group for Research on Adult Acute Lymphoblastic Leukemia intergroup.Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia.A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study.A critical review on properties and applications of microbial l-asparaginases.Targeting cancer cell metabolism in pancreatic adenocarcinoma.L-asparaginase and venous thromboembolism in acute lymphocytic leukemiaErythrocyte-mediated delivery of recombinant enzymes.Erythrocytes as Carriers for Drug Delivery in Blood Transfusion and Beyond.Drug delivery by erythrocytes: "Primum non nocere".Reengineering red blood cells for cellular therapeutics and diagnostics.Asparaginase pharmacology: challenges still to be faced.Safety, efficacy, and clinical utility of asparaginase in the treatment of adult patients with acute lymphoblastic leukemia.A phase 1/2 trial of lenalidomide and dexamethasone in adult patients with refractory/relapsed acute lymphoblastic leukemia.A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro.Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.The Modified Heparin-Binding L-Asparaginase of Wolinella succinogenes.
P2860
Q26747764-04F6A8B2-42EB-4CB1-BD4F-B16027071A2FQ26765322-72DD0033-E574-44B0-8B99-0A5B2176C61CQ26801300-16CD54C6-E88B-4679-B0BC-FA3679A12BAFQ26829775-80BC41A9-3415-492D-9A5D-7B4564F64EB9Q30243925-63FE9FE9-991E-4763-AE3A-C3198346D064Q30452351-C2DE9408-BFF3-44EC-945F-F5DEB10386E9Q33557148-1B9EADDC-B73A-4901-A571-6EF3E0D9BA5EQ36284750-6B30ABD2-5D00-4291-8296-ECB7B959F17FQ36382149-4037D793-85CE-4980-B29A-80CD10CC8DE3Q37132620-2182612B-88B7-4091-B2C3-1883C02D948FQ37352111-9F20EFC1-74B3-4387-900D-936013513CB6Q37454165-5F744FFC-1CCC-4552-A84A-6F8096EDA1ADQ37575938-923065F0-78E0-494B-ABD1-282452A0735FQ37968630-BBB838D2-0440-42D6-BB96-96061F6CBC9EQ38029631-527CB40A-6A63-4DC5-A944-7E482982827EQ38123856-6AA82FBF-5B1A-4B1A-8C8D-C14D2EA6BB82Q38189095-0CF78B4D-39C8-4306-A67B-86CDA2AF6C99Q38226402-1C85A486-5603-451F-91C0-8BA058DB3FD6Q38248280-C2547B62-F8D2-4E49-8DAF-17C1A03D31EAQ38409519-907F9A4D-017E-4031-96F2-F7EB616126B6Q38417141-053FD04B-ACB0-4E73-9D0E-874F5550CB16Q38545275-E9D50154-B01A-456B-8502-7A68021FE00DQ38566744-E7A39527-C71E-4B02-9AD7-6B07C0ECE8C0Q38793040-7846B6EC-4F89-429D-932E-62A946B96CB3Q38972974-1AD1F356-1120-4D93-8DFD-A0EA221CE693Q39011174-877FC7C1-686B-46B9-AF86-9AF44372E2D0Q39100275-38BF54DF-9EAE-4A18-AC2A-821D893454A8Q39135887-848B435E-72E1-4593-96BA-8BC5A329AD00Q39194553-79866969-E24F-4ADC-B980-8F941BB72000Q40473999-05BB51A0-085A-4C9C-B8A1-D26C5201BDDAQ44619167-19986113-86EC-4B18-B04E-2574BA033E65Q53713010-1B1CC639-E0C5-419D-835C-E89E52A627C1Q54245410-60BA663C-CDB5-47FF-8708-2C4686E0662A
P2860
l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
l-asparaginase loaded red bloo ...... PALL 2005-01 randomized trial.
@en
l-asparaginase loaded red bloo ...... PALL 2005-01 randomized trial.
@nl
type
label
l-asparaginase loaded red bloo ...... PALL 2005-01 randomized trial.
@en
l-asparaginase loaded red bloo ...... PALL 2005-01 randomized trial.
@nl
prefLabel
l-asparaginase loaded red bloo ...... PALL 2005-01 randomized trial.
@en
l-asparaginase loaded red bloo ...... PALL 2005-01 randomized trial.
@nl
P2093
P2860
P1476
l-asparaginase loaded red bloo ...... PALL 2005-01 randomized trial.
@en
P2093
Andre Baruchel
Anne Auvrignon
Carine Domenech
Claire Galambrun
David Liens
Dominique Rigal
Faezeh Legrand
François Gueyffier
Françoise Huguet
Françoise Mazingue
P2860
P356
10.1111/J.1365-2141.2011.08588.X
P407
P577
2011-02-20T00:00:00Z